BR100 Increased By (0.64%)
BR30 Increased By (0.86%)
KSE100 Increased By (0.39%)
KSE30 Increased By (0.41%)
BECO 6.10 Increased By ▲ 0.33 (5.72%)
BML 53.45 Increased By ▲ 0.45 (0.85%)
BOP 34.34 Increased By ▲ 0.35 (1.03%)
CNERGY 8.16 Increased By ▲ 0.05 (0.62%)
DCL 12.21 Increased By ▲ 0.01 (0.08%)
FCCL 53.39 Increased By ▲ 0.56 (1.06%)
FCSC 5.14 Increased By ▲ 0.07 (1.38%)
FFL 18.04 Increased By ▲ 0.09 (0.5%)
FNEL 1.32 Increased By ▲ 0.03 (2.33%)
HUMNL 10.94 Increased By ▲ 0.06 (0.55%)
KEL 8.13 Increased By ▲ 0.11 (1.37%)
KOSM 5.27 Decreased By ▼ -0.25 (-4.53%)
MLCF 87.24 Increased By ▲ 0.73 (0.84%)
NBP 187.00 Increased By ▲ 1.84 (0.99%)
PACE 10.67 Increased By ▲ 0.09 (0.85%)
PAEL 39.80 Increased By ▲ 0.38 (0.96%)
PIAHCLA 26.15 Decreased By ▼ -0.07 (-0.27%)
PIBTL 17.35 Increased By ▲ 0.68 (4.08%)
PPL 229.10 Increased By ▲ 0.92 (0.4%)
PRL 34.78 Increased By ▲ 0.10 (0.29%)
PTC 66.78 Increased By ▲ 1.45 (2.22%)
SEARL 90.62 Increased By ▲ 0.49 (0.54%)
SSGC 26.99 Increased By ▲ 0.39 (1.47%)
TELE 8.55 Increased By ▲ 0.27 (3.26%)
THCCL 58.45 Decreased By ▼ -0.05 (-0.09%)
TPLP 8.64 Increased By ▲ 0.42 (5.11%)
TREET 24.56 Increased By ▲ 0.03 (0.12%)
TRG 69.70 Decreased By ▼ -0.01 (-0.01%)
WAVES 9.96 Increased By ▲ 0.02 (0.2%)
WTL 1.29 Increased By ▲ 0.01 (0.78%)
Business & Finance

Pharma co’s decide not to increase drug prices

  • Accordingly, all medicines will remain available at old prices in the first quarter of this financial year.
Published August 22, 2020 Updated August 22, 2020 01:20pm

In order to support the government's initiative to provide relief to the people due to the COVID pandemic, the pharmaceutical companies have decided not to increase drug prices in the first quarter of this financial year.

The development comes in wake of government measures by keeping the prices static by interacting with the pharma industry, said Ministry of National Health Services, Regulation, and Coordination (NHS, R &C) spokesperson. Accordingly, all medicines will remain available at old prices in the first quarter of this financial year.

It is pertinent to mention that under Drug Pricing Policy 2018 pharmaceutical companies can increase prices of essential drugs by 7 percent and non-essential drugs by 10pc in accordance with annual consumer price index (CPI).

The spokesperson said that the government appreciates and commends the decision of the pharmaceutical companies and importers to stand with the government to provide relief to the people of Pakistan in this difficult time.

Back in July, the government has allowed a 7 to 10 percent increase in pharmaceutical prices. According to the Drug Regulatory Authority of Pakistan (DRAP) announcement, pharmaceutical companies, and importers were allowed to increase the prices of lifesaving medicines by 7pc while the prices of other medicines by 10pc.

Comments

Comments are closed for this article.